Create a Free Account
or
Create a Free Account
or
| # | Filing Date | Period End Date | Type | Report Link |
|---|---|---|---|---|
| No Data found | ||||
| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
Here's a roundup of top developments in the biotech space over the last 24 hours.
Today's 5 Stock Ideas: Boeing (BA) - Shares were down 6% Monday morning following the crash of a China Eastern Airline...
Biotech stocks rebounded along with the broader market in the week ending March 18, as risk appetite returned. Multiple confere...
Merger activity increased last week with six new deals announced and six deals completed. Three of the six new deals announced ...
Zogenix (NASDAQ:ZGNX), a global biopharmaceutical company developing and commercializing rare disease therapies, announced that...
The Food and Drug Administration approval calendar was light in February. Nevertheless, the month saw regulatory nods accorded ...
Zogenix (NASDAQ:ZGNX) reported its Q4 earnings results on Monday, February 28, 2022 at 08:00 AM. Here's what investors ...
Zogenix (NASDAQ:ZGNX) reported quarterly losses of $(0.98) per share. This is a 22.22 percent increase over losses of $(1.26) p...
Zogenix (NASDAQ:ZGNX), a global biopharmaceutical company developing rare disease therapies, today announced that the company i...
